Last reviewed · How we verify
JS006 in combination with Toripalimab
JS006 in combination with Toripalimab is a Small molecule drug developed by Shanghai Junshi Bioscience Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | JS006 in combination with Toripalimab |
|---|---|
| Sponsor | Shanghai Junshi Bioscience Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors (PHASE1)
- A Study of JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies (PHASE1)
- A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies (PHASE1)
- The Recombinant Humanized Anti-TIGIT Monoclonal Antibody (JS006) Monotherapy and in Combination With Toripalimab in Patients With Advanced Tumor (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- JS006 in combination with Toripalimab CI brief — competitive landscape report
- JS006 in combination with Toripalimab updates RSS · CI watch RSS
- Shanghai Junshi Bioscience Co., Ltd. portfolio CI
Frequently asked questions about JS006 in combination with Toripalimab
What is JS006 in combination with Toripalimab?
JS006 in combination with Toripalimab is a Small molecule drug developed by Shanghai Junshi Bioscience Co., Ltd..
Who makes JS006 in combination with Toripalimab?
JS006 in combination with Toripalimab is developed by Shanghai Junshi Bioscience Co., Ltd. (see full Shanghai Junshi Bioscience Co., Ltd. pipeline at /company/shanghai-junshi-bioscience-co-ltd).
What development phase is JS006 in combination with Toripalimab in?
JS006 in combination with Toripalimab is in Phase 1.